Trupanion, Inc. (NASDAQ:TRUP) Insider Brenna Mcgibney Sells 5,000 Shares

Trupanion, Inc. (NASDAQ:TRUPGet Free Report) insider Brenna Mcgibney sold 5,000 shares of the stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $32.99, for a total value of $164,950.00. Following the completion of the transaction, the insider now directly owns 3,738 shares of the company’s stock, valued at $123,316.62. This trade represents a 57.22 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Trupanion Trading Up 2.7 %

Shares of TRUP stock opened at $34.09 on Thursday. The stock has a 50-day simple moving average of $43.21 and a 200 day simple moving average of $47.24. The stock has a market capitalization of $1.45 billion, a P/E ratio of -148.22, a P/E/G ratio of 6.02 and a beta of 1.70. Trupanion, Inc. has a fifty-two week low of $19.69 and a fifty-two week high of $57.90. The company has a quick ratio of 1.66, a current ratio of 1.71 and a debt-to-equity ratio of 0.39.

Trupanion (NASDAQ:TRUPGet Free Report) last posted its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.02). Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The business had revenue of $337.31 million for the quarter, compared to the consensus estimate of $335.41 million. On average, sell-side analysts expect that Trupanion, Inc. will post 0.13 earnings per share for the current fiscal year.

Analyst Ratings Changes

TRUP has been the subject of several recent analyst reports. Stifel Nicolaus decreased their price target on Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a research note on Thursday, February 20th. Piper Sandler decreased their target price on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a research report on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $46.60.

Get Our Latest Analysis on Trupanion

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in TRUP. Sigma Planning Corp bought a new stake in shares of Trupanion during the 3rd quarter worth $336,000. Entropy Technologies LP purchased a new stake in shares of Trupanion during the third quarter valued at $202,000. GSA Capital Partners LLP lifted its holdings in shares of Trupanion by 51.3% during the third quarter. GSA Capital Partners LLP now owns 10,487 shares of the financial services provider’s stock valued at $440,000 after purchasing an additional 3,554 shares during the last quarter. Victory Capital Management Inc. acquired a new position in shares of Trupanion in the 3rd quarter valued at $261,000. Finally, Check Capital Management Inc. CA increased its stake in Trupanion by 2.7% in the 3rd quarter. Check Capital Management Inc. CA now owns 41,460 shares of the financial services provider’s stock worth $1,740,000 after purchasing an additional 1,100 shares in the last quarter.

About Trupanion

(Get Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Read More

Insider Buying and Selling by Quarter for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.